Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665782 · ClinicalTrials.gov registry record
Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 24
- Enrollment target
NCT00665782: Completed study, sponsored by Wake Forest University Health Sciences.
NCT00665782 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00665782 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about how patients respond to stress and measuring stress levels in women with newly diagnosed breast cancer may help doctors provide better methods of treatment and on-going care. PURPOSE: This research study is measuring stress in women with newly diagnosed stage I, stage II, or stage III breast cancer or ductal carcinoma in situ of the breast.
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- OTHER study of socioeconomic and demographic variables
- PROCEDURE psychosocial assessment and care
- PROCEDURE assessment of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-07 |
What the finished NCT00665782 record still lists
NCT00665782 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00665782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00665782 about?
NCT00665782 is a clinical study titled "Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast". RATIONALE: Gathering information about how patients respond to stress and measuring stress levels in women with newly diagnosed breast cancer may help doctors provide better methods of treatment and on-going care. PURPOSE: This research study is measuring stress in women with newly diagnosed stage ...
What is the current status of trial NCT00665782?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2008-03. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00665782?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), study of socioeconomic and demographic variables (OTHER), psychosocial assessment and care (PROCEDURE), assessment of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00665782?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia